Integer (ITGR) Competitors

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Do analysts rate ITGR or BDSX?

Integer presently has a consensus target price of $140.25, indicating a potential upside of 34.80%. Biodesix has a consensus target price of $32.50, indicating a potential upside of 315.87%. Given Biodesix's higher possible upside, analysts plainly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00
Biodesix	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Which has stronger earnings & valuation, ITGR or BDSX?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.72B	2.12	$119.90M	$2.27	45.83
Biodesix	$71.32M	0.80	-$42.93M	-$5.80	-1.35

Does the media refer more to ITGR or BDSX?

In the previous week, Biodesix had 4 more articles in the media than Integer. MarketBeat recorded 7 mentions for Biodesix and 3 mentions for Integer. Biodesix's average media sentiment score of 1.41 beat Integer's score of 0.83 indicating that Biodesix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Biodesix	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is ITGR or BDSX more profitable?

Integer has a net margin of 4.61% compared to Biodesix's net margin of -53.66%. Integer's return on equity of 12.27% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	4.61%	12.27%	6.23%
Biodesix	-53.66%	-269.67%	-43.94%

Which has more volatility and risk, ITGR or BDSX?

Integer has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500. Comparatively, Biodesix has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.

Do insiders & institutionals believe in ITGR or BDSX?

99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 2.2% of Integer shares are owned by insiders. Comparatively, 30.1% of Biodesix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Integer beats Biodesix on 13 of the 17 factors compared between the two stocks.